Place of Origin : Beijing,China
Post Date : 22-06-2021
Expiry Date : 31-12-2021

Founded In 1992, Beijing Beilu Pharmaceuticals Company Limited Is Mainly Engaged In The Research & Development, Production And Sales Of Pharmaceutical Products. It Is High-tech Innovation Company With Core Competence In The Contrast Media Domestic. It Has Around 650 Employees With 0.82 Bn/? Revenue In 2019. Beilu Provides Complete Contrast Media Products Include ct Contrast Medium, Mri Contrast Medium, Gadopentetate Dimeglumine,etc, And It Is The Leading Manufacturer In The Contrast Media Field In China. It Is One Of The 1st Batches Of Listed Enterprises In GEM Of SZSE (Ticker: 300016.SZ) In China.

In 2020, Beilu Launched Its Macrocyclic Contrast Media- Gadobutrol Injection, It Is Gadolinium-based Non-ionic Contrast Media, A Paramagnetic Contrast Media Used In Various Parts Of The Body Lesion (including The Brain And Spinal Cord) MRI Imaging And Angiography Examination. Its Macrocyclic Nature Ensures It Is Well-tolerated With A Good Safety Profile For MRI Contrast. As A Professional Contrast Media Manufacturer, Beilu Can Provide You With The High Concentration gadobutrol Gadovist That Leads To A Better Image With Lower Volume.

Product Name: Gadobutrol Injection
Generic Name: Gadobutrol Injection
Type: Injectable Contrast Media For MRI, Macrocyclic Contrast Media
Ingredients: Gadobutrol
Specification: Gadovist 7.5 Ml - 4.5354 G, Injection Gadobutrol 0.1 Ml
Administration: Intravenous Administration Only.
Adverse Reactions: See The Details From The Package Insert.

Shelf Life: 24 Months
Indication Of Gadopentetate Dimegumine Injection
Magnetic Resonance Imaging Of The Central Nervous System (brain And Spinal Cord), Abdomen, Chest, Pelvis, Limbs And Other Human Organs And Tissues.